top of page

Our Team

​

michael headshot.png

Michael Jay, Ph. D.

  • LinkedIn

Founder

40+ years in drug development, formulations, and imaging agents. Fred Eshelman Chair & Emeritus Professor (retired) of molecular pharmaceuticals at UNC Chapel Hill.

unnamed.jpg

Jeffrey Miller

Chairman and Chief Executive Officer 

  • LinkedIn

>30 years in biopharma industry: Eli Lilly, Boehringer Ingelheim, Alexion, Alnylam. Worked in over 20 countries; lived abroad for 25% of career. Co-founder of TSP Therapeutics.

Alanheadshots2023-10_edited.jpg

Alan Parr, Pharm. D., Ph. D.

  • LinkedIn

Chief Technical Officer

35+ Years in pharmaceutical industry; involved with numerous FDA and EMA regulatory submissions. Principal Investigator on Phase 2 SBIR grant.

kevin pic.jpeg

Kevin Byrd, DDS., Ph. D. 

  • LinkedIn

Advisor

DDS, University of Michigan. Ph. D., Oral and Craniofacial Biomedicine, UNC. Volpe Research Scholar. Manager of Oral & Craniofacial Research, American Dental Association Science & Research Institute. 

Rob G photo_edited.jpg

Rob Glanzman, M.D., FAAN 

  • LinkedIn

Clinical Development Leader

>20 years of clinical development as CMO & in executive leadership roles. Pfizer, Novartis, Nektar, Purdue, Find Therapeutics. Advanced numerous drugs from Ph 1 to Ph 3 & on to FDA approval.

Miller Pfp.png

Alexandra Miller

  • LinkedIn

Intern

Senior at Hobart & William Smith Colleges double majoring in Economics and Biology to prepare for career in biopharma. 

bottom of page